Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate - Kawasaki, Isao; Hiura, Yoshikazu; Tamai, Anna; Yoshida, Yoko; Yakusiji, Yosuke; Ikuno, Yoshiko; Okada, Megumi; Ueno, Hiroki; Tanaka, Nagaaki; Yamagami, Keiko; Fukumoto, Mariko; Hosoi, Masayuki (Journal of diabetes, 2015)
Keywords: Albuminuria - prevention & control; Blood Pressure - drug effects; Creatinine - urine; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - physiopathology; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - etiology; Diabetic Nephropathies - physiopathology; Female; Glomerular Filtration Rate; Glycated Hemoglobin A - analysis; Humans; Hypoglycemic Agents - therapeutic use; Kidney Function Tests; Male; Middle Aged; Pyrazines - therapeutic use; Sitagliptin Phosphate; Triazoles - therapeutic use; albumin-to-creatinine ratio; sitagliptin; 关键词：白蛋白/肌酐比值，糖尿病肾病，西格列汀; diabetic nephropathy